Beranda › Talasemia Beta › New York
Uji klinis Talasemia Beta di New York
5 studi untuk Talasemia Beta mencari peserta di lokasi di New York.
Teks studi resmi (Bahasa Inggris)
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- New York Presbyterian Hospital, New York
Menerima pesertaFase 2
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
Menerima pesertaFase 2
Usia 2 hingga 50 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Menerima pesertaFase 3
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT05477563AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
Menerima pesertaFase 2
1 Day – 30 Years · Semua jenis kelamin · Diperbarui 8 Agu 2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Cohen Children's Medical Center, New Hyde Park
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 11 Feb 2025 · NCT06271512Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.